Career marked by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis
Maintenance of Remission in ANCA-Associated Vasculitis
Relapses are common, but difficult to predict and prevent.
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Coding Corner Question: September’s Coding Challenge
How the case is coded.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
Why Did Rheumatoid Arthritis Begin in 1800?
The connection between periodontal disease and RA.
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis
Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.
Newly Discovered Molecule Modulates Cartilage Repair
Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.
- « Previous Page
- 1
- …
- 297
- 298
- 299
- 300
- 301
- …
- 339
- Next Page »